NEW YORK, Aug. 19, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Bionik Laboratories Corp. (OTCQX: BNKL), an innovative medical device and robotics company, has qualified to trade on the OTCQX® Best Market.
Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO
Bionik begins trading today on OTCQX under its existing ticker symbol "BNKL." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"Bionik is developing exciting robotic technologies to help people with impaired mobility walk again," said R. Cromwell Coulson, President and CEO of OTC Markets Group. "We are pleased to welcome Bionik to the OTCQX market and look forward to supporting the company in its continued growth and evolution as a publicly-traded company."
Peter Bloch, CEO of Bionik, stated, "Upgrading to the OTCQX market is an important step forward for Bionik as we continue to focus our efforts on advancing and deploying our innovative medical-robotic healthcare solutions towards commercialization and prepare to execute on our growth strategy."
Ruskin Moscou Faltischek, PC serves as Bionik's Designated Advisor for Disclosure ("DAD") on OTCQX, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.
Bionik is a pioneering medical device and robotics company with a focus in developing transformational technologies and solutions for individuals with neurological disorders. The Bionik team has researched, developed and tested its primary product, The ARKE™, a robotic lower-body exoskeleton device that allows paraplegics and as well as other wheelchair users the ability to rehabilitate through walking and other motion.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
Saskia Sidenfaden
OTC Markets Group Inc.
+1 (212) 896-4428
saskia@otcmarkets.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-bionik-laboratories-to-otcqx-300130383.html
SOURCE OTC Markets Group Inc.